{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:32:03Z","timestamp":1790728323919,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T00:00:00Z","timestamp":1182297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11926-007-0035-9","type":"journal-article","created":{"date-parts":[[2007,6,19]],"date-time":"2007-06-19T00:30:51Z","timestamp":1182213051000},"page":"219-225","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome?"],"prefix":"10.1007","volume":"9","author":[{"given":"Erin A. S.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Silver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ware Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,6,20]]},"reference":[{"key":"35_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S. Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al.: International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006, 4:295\u2013306.","journal-title":"J Thromb Haemost"},{"key":"35_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1160\/TH05-02-0081","volume":"94","author":"G. Reber","year":"2005","unstructured":"Reber G, Tincani A, Sanmarco M, et al.: European Forum on Antiphopholipid Antibodies Standardization Group. Variability of anti-beta2 glycoprotein I antibodies measurement by commercial assays. Thromb Haemost 2005, 94:665\u2013672.","journal-title":"Thromb Haemost"},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1016\/S0140-6736(83)92141-4","volume":"i","author":"W.F. Lubbe","year":"1983","unstructured":"Lubbe WF, Palmer SJ, Butler WS, et al.: Fetal survival after prednisone suppression of maternal lupus anticoagulant. Lancet 1983, i:1361.","journal-title":"Lancet"},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1056\/NEJM198511213132104","volume":"313","author":"D.W. Branch","year":"1985","unstructured":"Branch DW, Scott JR, Kochenour NK, et al.: Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985, 313:1322\u20131326.","journal-title":"N Engl J Med"},{"key":"35_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJM198507183130304","volume":"313","author":"M.D. Lockshin","year":"1985","unstructured":"Lockshin MD, Druzin ML, Goei S, et al.: Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985, 313:152\u2013156.","journal-title":"N Engl J Med"},{"key":"35_CR6","first-page":"614","volume":"80","author":"D.W. Branch","year":"1992","unstructured":"Branch DW, Silver RM, Blackwell JL, et al.: Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992, 80:614\u2013620.","journal-title":"Obstet Gynecol"},{"key":"35_CR7","first-page":"970","volume":"82","author":"A. Caruso","year":"1993","unstructured":"Caruso A, de Carolis S, Ferrazzani S, et al.: Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993, 82:970\u2013977.","journal-title":"Obstet Gynecol"},{"key":"35_CR8","first-page":"131","volume":"14","author":"F. Lima","year":"1996","unstructured":"Lima F, Khamashta MA, Buchanan NM, et al.: A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996, 14:131\u2013136.","journal-title":"Clin Exp Rheumatol"},{"key":"35_CR9","first-page":"2025","volume":"28","author":"D.L. Huong","year":"2001","unstructured":"Huong DL, Wechsler B, Bletry O, et al.: A study of 75 pregnancies in patients with antiphospholipid syndrome. J Rheumatol 2001, 28:2025\u20132030.","journal-title":"J Rheumatol"},{"key":"35_CR10","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1055\/s-0037-1616739","volume":"86","author":"R. Pauzner","year":"2001","unstructured":"Pauzner R, Dulitzki M, Langevitz P, et al.: Low molecular weight heparin and warfarin in the treatment of patients with antiphospholipid syndrome during pregnancy. Thromb Haemost 2001, 86:1379\u20131384.","journal-title":"Thromb Haemost"},{"key":"35_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0002-9378(89)90468-7","volume":"160","author":"M.D. Lockshin","year":"1989","unstructured":"Lockshin MD, Druzin ML, Qamar T: Prednisone does not prevent recurrent fetal death in women with antiphospholipid antibody. Am J Obstet Gynecol 1989, 160:439\u2013443.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR12","first-page":"1108","volume":"78","author":"W.J. Polzin","year":"1991","unstructured":"Polzin WJ, Kopelman JN, Robinson RD, et al.: The association of aPL with pregnancies complicated by fetal growth restriction. Obstet Gynecol 1991, 78:1108\u20131111.","journal-title":"Obstet Gynecol"},{"key":"35_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3109\/00016349209007966","volume":"71","author":"K.E. Sletnes","year":"1992","unstructured":"Sletnes KE, Wisloff F, Moe N, et al.: Antiphospholipid antibodies in pre-eclamptic women: relation to growth retardation and neonatal outcome. Acta Obstet Gynecol Scand 1992, 71:112\u2013117.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"35_CR14","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0029-7844(95)00247-O","volume":"86","author":"M. Yasuda","year":"1995","unstructured":"Yasuda M, Takakuwa K, Tokunaga A, et al.: Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol 1995, 86:555\u2013559.","journal-title":"Obstet Gynecol"},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-0528.1993.tb15105.x","volume":"100","author":"N.S. Pattison","year":"1993","unstructured":"Pattison NS, Chamley LW, McKay EJ, et al.: Antiphospholipid antibodies in pregnancy: prevalence and clinical associations. BJOG 1993, 100:909\u2013913.","journal-title":"BJOG"},{"key":"35_CR16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.7326\/0003-4819-120-6-199403150-00004","volume":"120","author":"A. Lynch","year":"1994","unstructured":"Lynch A, Marlar R, Murphy J, et al.: Antiphospholipid antibodies in predicting adverse pregnancy outcome: a prospective study. Ann Intern Med 1994, 120:470\u2013475.","journal-title":"Ann Intern Med"},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","volume":"174","author":"W.H. Kutteh","year":"1996","unstructured":"Kutteh WH: Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol 1996, 174:1584\u20131589.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0002-9378(91)90222-D","volume":"165","author":"J. Milliez","year":"1991","unstructured":"Milliez J, Lelong F, Bayani N, et al.: The prevalence of autoantibodies during third-trimester pregnancy complicated by hypertension or idiopathic fetal growth retardation. Am J Obstet Gynecol 1991, 165:51\u201356.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1365-2249.1993.tb06000.x","volume":"94","author":"T. Yamamoto","year":"1993","unstructured":"Yamamoto T, Yoshimura S, Geshi Y, et al.: Measurement of antiphospholipid antibody by WLISA using purified beta2-glycoprotein I in preeclampsia. Clin Exp Immunol 1993, 94:196\u2013200.","journal-title":"Clin Exp Immunol"},{"key":"35_CR20","first-page":"105","volume":"85","author":"J. Moodley","year":"1995","unstructured":"Moodley J, Bhoola V, Duursma J, et al.: The association of antiphospholipid antibodies with severe early-onset preeclampsia. S Afr Med J 1995, 85:105\u2013107.","journal-title":"S Afr Med J"},{"key":"35_CR21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0897.1996.tb00143.x","volume":"36","author":"J.Y. Allen","year":"1996","unstructured":"Allen JY, Tapia-Santiago C, Kutteh WH: Antiphospholipid antibodies in patients with preeclampsia. Am J Reprod Immunol 1996, 36:81\u201385.","journal-title":"Am J Reprod Immunol"},{"key":"35_CR22","first-page":"541","volume":"73","author":"D.W. Branch","year":"1989","unstructured":"Branch DW, Andres R, Digre KB, et al.: The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol 1989, 73:541\u2013545.","journal-title":"Obstet Gynecol"},{"key":"35_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/0002-9378(95)91324-6","volume":"173","author":"G.A. Dekker","year":"1995","unstructured":"Dekker GA, de Vries JI, Doelitzsch PM, et al.: Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995, 173:1042\u20131048.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR24","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0002-9378(99)70608-3","volume":"180","author":"M.G. van Pampus","year":"1999","unstructured":"van Pampus MG, Dekker GA, Wolf H, et al.: High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999, 180:1146\u20131150.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR25","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/j.1471-0528.1987.tb03162.x","volume":"94","author":"R.A. Scott","year":"1987","unstructured":"Scott RA: Anticardiolipin antibodies and pre-eclampsia. BJOG 1987, 94:604\u2013605.","journal-title":"BJOG"},{"key":"35_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0002-9378(11)91619-6","volume":"167","author":"H.J. Out","year":"1992","unstructured":"Out HJ, Bruinse HW, Christiaens GC, et al.: A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992, 167:26\u201332.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR27","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0301-2115(96)02574-2","volume":"70","author":"G. Uncu","year":"1996","unstructured":"Uncu G, Ozan H, Kucukerdogan I, et al.: Anticardiolipin antibodies in pregnancy induced hypertension. Eur J Obstet Gynecol Reprod Biol 1996, 70:97\u2013100.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"35_CR28","first-page":"135","volume":"24","author":"R. D\u2019Anna","year":"1997","unstructured":"D\u2019Anna R, Scilipoti A, Leonardi J, et al.: Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation. Clin Exp Obstet Gynecol 1997, 24:135\u2013137.","journal-title":"Clin Exp Obstet Gynecol"},{"key":"35_CR29","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1159\/000010166","volume":"48","author":"E. Martinez-Abundis","year":"1999","unstructured":"Martinez-Abundis E, Gonzalez-Ortiz M, Cortes-Llamas V, et al.: Anticardiolipin antibodies and the severity of preeclampsia-eclampsia. Gynecol Obstet Invest 1999, 48:168\u2013171.","journal-title":"Gynecol Obstet Invest"},{"key":"35_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0301-2115(98)00233-4","volume":"83","author":"L.S. Matthiesen","year":"1999","unstructured":"Matthiesen LS, Berg G, Ernerudh J, et al.: A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 1999, 83:21\u201326.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"35_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0029-7844(00)01099-1","volume":"97","author":"M. Dreyfus","year":"2001","unstructured":"Dreyfus M, Hedelin G, Kutnahorsky R, et al.: Antiphospholipid antibodies and preeclampsia: A case-control study. Obstet Gynecol 2001, 97:29\u201334.","journal-title":"Obstet Gynecol"},{"key":"35_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/bmj.38380.674340.E0","volume":"330","author":"K. Duckitt","year":"2005","unstructured":"Duckitt K, Harrington D: Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005, 330:565\u2013571.","journal-title":"BMJ"},{"key":"35_CR33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1067\/mob.2001.113846","volume":"184","author":"D.W. Branch","year":"2001","unstructured":"Branch DW, Porter TF, Rittenhouse L, et al.: Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001, 184:825\u2013832.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR34","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1055\/s-2004-829870","volume":"21","author":"G.G. Zeeman","year":"2004","unstructured":"Zeeman GG, Alexander JM, McIntire DD, et al.: The significance of antiphospholipid antibodies in pregnant women with chronic hypertension. Am J Perinat 2004, 21:275\u2013279.","journal-title":"Am J Perinat"},{"key":"35_CR35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/HUMREP\/11.3.509","volume":"11","author":"K. Katano","year":"1996","unstructured":"Katano K, Aoki A, Sasa H, et al.: Beta2-glycoprotein I-dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996, 11:509\u2013512.","journal-title":"Hum Reprod"},{"key":"35_CR36","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0301-2115(97)02736-X","volume":"73","author":"D. Faden","year":"1997","unstructured":"Faden D, Tincani A, Tanzi P, et al.: Anti-beta 2 glycoprotein I antibodies in a general obstetric population: Preliminary results on the prevalence and correlation with pregnancy outcome. Anti-beta2-glycoprotien I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Eur J Obstet Gynecol Reprod Biol 1997, 73:37\u201342.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"35_CR37","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/0002-9378(91)90348-U","volume":"165","author":"E.N. Harris","year":"1991","unstructured":"Harris EN, Spinnato JA: Should anticardiolipin tests be performed in otherwise healthy pregnant women?\n                           Am J Obstet Gynecol 1991, 165:1272\u20131277.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0029-7844(03)00477-0","volume":"102","author":"R.M. Lee","year":"2003","unstructured":"Lee RM, Brown MA, Branch DW, et al.: Anticardiolipin and anti-beta2-glycoprotein-I antibodies in preeclampsia. Obstet Gynecol 2003, 102:294\u2013300.","journal-title":"Obstet Gynecol"},{"key":"35_CR39","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/S0029-7844(03)00363-6","volume":"101","author":"D.W. Branch","year":"2003","unstructured":"Branch DW, Khamashta MA: Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Am J Obstet Gynecol 2003, 101:1333\u20131344.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1056\/NEJM199707173370303","volume":"337","author":"J.H. Rand","year":"1997","unstructured":"Rand JH, Wu XX, Andree HA, et al.: Pregnancy loss in the antiphospholipid-antibody syndrome\u2014a possible thrombogenic mechanism. N Engl J Med 1997, 337:154\u2013160. [Published erratum in: N Engl J Med 1997, 337:1327.]","journal-title":"N Engl J Med"},{"key":"35_CR41","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.placenta.2003.12.006","volume":"25","author":"J.T. Van Horn","year":"2004","unstructured":"Van Horn JT, Craven C, Ward K, et al.: Histologic features of placentas and abortion specimens from women with anti-phospholipid and antiphospholipid-like syndromes. Placenta 2004, 25:642\u2013648.","journal-title":"Placenta"},{"key":"35_CR42","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P","volume":"43","author":"N. Di Simone","year":"2000","unstructured":"Di Simone N, Meroni PL, de Papa N, et al.: Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000, 43:140\u2013150.","journal-title":"Arthritis Rheum"},{"key":"35_CR43","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","volume":"17","author":"N.J. Sebire","year":"2002","unstructured":"Sebire NJ, Fox H, Backos M, et al.: Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated early pregnancy failure. Hum Reprod 2002, 17:1067\u20131071.","journal-title":"Hum Reprod"},{"key":"35_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0143-4004(98)90100-X","volume":"19","author":"C.M. Salafia","year":"1998","unstructured":"Salafia CM, Pezzullo JC, Ghidini A, et al.: Clinical correlations of patterns of placental pathology in preterm preeclampsia. Placenta 1998, 19:67\u201372.","journal-title":"Placenta"},{"key":"35_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1067\/mob.2002.119176","volume":"186","author":"N. Ishihara","year":"2002","unstructured":"Ishihara N, Natsuo H, Murakoshi H, et al.: Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol 2002, 186:158\u2013166.","journal-title":"Am J Obstet Gynecol"},{"key":"35_CR46","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1002\/tera.10107","volume":"66","author":"S. Yacobi","year":"2002","unstructured":"Yacobi S, Ornoy A, Blumenfeld Z, Miller RK: Effect of sera from women with systemic lupus erythematosus or antiphospholipid syndrome and recurrent abortions on human placental explants in culture. Teratology 2002, 66:300\u2013308.","journal-title":"Teratology"},{"key":"35_CR47","doi-asserted-by":"crossref","unstructured":"Albrecht C, Soumian S, Tetlow N, et al.: Placental ABCA1 expression is reduced in primary antiphospholipid syndrome compared to pre-eclampsia and controls. Placenta 2006, Epub ahead of print.","DOI":"10.1016\/j.placenta.2006.10.001"},{"key":"35_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1084\/jem.200116116","volume":"195","author":"V.M. Holers","year":"2002","unstructured":"Holers VM, Giradi G, Mo L, et al.: Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 2002, 195:211\u2013220.","journal-title":"J Exp Med"},{"key":"35_CR49","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"J.S. Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J: The antiphospholipid syndrome. N Engl J Med 2002, 346:752\u2013763.","journal-title":"N Engl J Med"},{"key":"35_CR50","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/1529-0131(200002)43:2<440::AID-ANR26>3.0.CO;2-N","volume":"43","author":"M.D. Lockshin","year":"2000","unstructured":"Lockshin MD, Sammaritano LR, Schwartzman S: Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000, 43:440\u2013443.","journal-title":"Arthritis Rheum"},{"key":"35_CR51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0095-5108(18)30168-4","volume":"24","author":"R.M. Silver","year":"1997","unstructured":"Silver RM, Branch DW: Autoimmune disease in pregnancy: Systemic lupus erythematosus and anti-phospholipid syndrome. Clin Perinatol 1997, 24:291\u2013320.","journal-title":"Clin Perinatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-007-0035-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0035-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-007-0035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T12:47:32Z","timestamp":1652618852000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-007-0035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,20]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["35"],"URL":"https:\/\/doi.org\/10.1007\/s11926-007-0035-9","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,20]]},"assertion":[{"value":"20 June 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}